Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis

Hepatology

Volumn 29, Issue 1, 1999, Pages 21-26

  Pasha, Tousif ^a   Heathcote, Jenny ^b   Gabriel, Sherine ^a   Cauch Dudek, Karen ^b   Jorgensen, Roberta ^a   Therneau, Terry ^a   Rolland Dickson, E ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILIARY CIRRHOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CANADA; CHOLAGOGUES AND CHOLERETICS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HUMANS; LIFE EXPECTANCY; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; UNITED STATES; URSODEOXYCHOLIC ACID;

EID: 0032923457     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290116     Document Type: Article

References (21)

1. Laurin JM, Lindor KD. Primary biliary cirrhosis. Dig Dis 1994;12:331-350.
2. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1987;316:521-529.
3. Bodenheimer Jr H, Schaffner F, Penzzullo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 1988;95:124-129.
4. Wiesner RH, Ludwig J, Lindor K, Jorgensen RA, Baldus WP, Homburger HA, Dickson ER. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med 1990;322:1419.
5. Heathcote J, Ross A, Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976;70:656.
6. Dickson ER, Fleming TR, Wiesner RH, Baldus WP, Fleming CR, Ludwig J, McCall JT. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985;312:1011-1015.
7. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996;110:1515-1518.
8. Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991;324:1548-1554.
9. Poupon RE, Poupon R, Balkau B, UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-1347.
10. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, et al. The Canadian multicenter double-blinded randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1994;19:1149-1156.
11. Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-1290.
12. Combes B, Carithers RL, Maddrey WC, Lin D, McDonald MF, Wheeler DE, Eigenbrodt EH, et al. A randomized double-blinded, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1995;22:759-766.
13. Dufour MC. Chronic liver disease and cirrhosis. In: Everhart JE, ed. Digestive Diseases in the United States: Epidemiology and Impact. US Department of Health and Human Services, Public Health Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington DC: US Government Printing Office, 1994:NIH publication no. 94-1447:613-646.
14. Sifton DW. 1995 Drug topics red book: pharmacy's fundamental reference. Montvale, NJ: Medical Economics Co., Inc., 1995.
15. Poupon RE, Lindor KD, Cauch K, Dickson ER, Poupon R, Heathcote J. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.
16. Lindfors KK, Rosenquist CJ. The cost-effectiveness of mammographic screening strategies. JAMA 1995;274:881-884.
17. Kinosian BP, Eisenberg JM. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia. JAMA 1988;259:2249-2254.
18. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-1258.
19. Witt-Sullivan H, Heathcote J, Cauch K, Blendis L, Ghent C, Katz A, Milner R, et al. The demography of primary biliary cirrhosis in Ontario, Canada. HEPATOLOGY 1990;12:98-105.
20. Villeneuve J, Fenyves D, Infante-Rivard C. Descriptive epidemiology of primary biliary cirrhosis in the province of Quebec. Can J Gastroenterol 1991;5:174-178.
21. Metcalf J, James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 1997;17:13-22.